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Abstract
Background Conversion from laparoscopic to open access colorectal surgery is associated with a poorer postoperative out-
come. The aim of this study was to assess conversion rates and outcomes after standard laparoscopic rectal resection (LR) 
and robotic laparoscopic rectal resection (RR).
Methods A national 5-year cohort study utilizing prospectively recorded data on patients who underwent elective major 
laparoscopic resection for rectal cancer. Data were retrieved from the Norwegian Registry for Gastrointestinal Surgery and 
from the Norwegian Colorectal Cancer Registry. Primary end point was conversion rate. Secondary end points were postop-
erative complications within 30 days and histopathological results. Chi-square test, two-sided T test, and Mann–Whitney U 
test were used for univariable analyses. Both univariable and multivariable logistic regression analyses were used to analyze 
the relations between different predictors and outcomes, and propensity score matching was performed to address potential 
treatment assignment bias.
Results A total of 1284 patients were included, of whom 375 underwent RR and 909 LR. Conversion rate was 8 out of 375 
(2.1%) for RR compared with 87 out of 909 (9.6%) for LR (p < 0.001). RR was associated with reduced risk for conversion 
compared with LR (aOR 0.22, 95% CI 0.10–0.46). There were no other outcome differences between RR and LR. Factors 
associated with increased risk for conversion were male gender, severe cardiac disease and BMI > 30. Conversion was asso-
ciated with higher rates of major complications (20 out of 95 (21.2%) vs 135 out of 1189 (11.4%) p = 0.005), reoperations 
(13 out of 95 (13.7%) vs 93 out of 1189 (7.1%) p = 0.020), and longer hospital stay (median 8 days vs 6 days, p = 0.001).
Conclusion Conversion rate was lower with robotic assisted rectal resections compared with conventional laparoscopy. 
Conversions were associated with higher rates of postoperative complications.
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Over the last 10 years, laparoscopic rectal resection has 
become the preferred approach in many countries [1, 2]. 
While several studies have shown favorable outcomes after 
laparoscopic surgery for colon cancer [3–7] with reduced 
rates of postoperative complications, 30-day mortality, and 
long-term results equal to open access surgery [8–10], the 
results after laparoscopic rectal cancer surgery have not been 
unambiguously positive. Although studies demonstrate simi-
lar short- and long-term results compared to open access sur-
gery [11, 12], unfavorable histopathological outcomes with 
higher rates of positive circumferential resection margins, 
and lower rates of complete excision of mesorectum after 
TME have been reported [13, 14].
Due to a narrow operative field in the pelvis and limited 
instrument mobility, laparoscopic surgery for rectal cancer is 
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technically demanding. Studies have shown conversion rates 
between 12 and 30% [15–18], and a need of about 150 oper-
ations to flatten the learning curve [19]. These disadvantages 
may be overcome with robotic assisted laparoscopic access 
which offers a three-dimensional view with a stable camera, 
better ergonomic conditions, enhanced dexterity, and instru-
ment articulation. This might facilitate a more precise dis-
section with improved specimen quality. In particular, it may 
also reduce the need for conversion, which is associated with 
higher complication rates [3, 15, 20]. While several stud-
ies have shown lower conversion rates with robotic assisted 
laparoscopy compared to conventional laparoscopy [16, 21, 
22], this could not be confirmed in the large randomized 
ROLARR trial [23].
The aim of this study was to assess conversion rates after 
standard laparoscopic versus robotic assisted laparoscopic 
resections for rectal cancer, as well as postoperative compli-
cations within the first 30 days and histopathological results 
in a national cohort from the Norwegian registry for gastro-
intestinal surgery (NoRGast) [24] supplied with data from 
the Norwegian Colorectal Cancer Registry [25].
Materials and methods
Study population
Patients who underwent elective major resection for rectal 
cancer from January 1st 2014 to December 31st 2018 were 
identified via the Norwegian Registry for Gastrointestinal 
Surgery (NoRGast) [24]. Due to some delay in data regis-
try, and also to achieve at least 6 months follow-up, latest 
operation date for data extraction was set to December 2018. 
This national quality registry was established in 2014, and 
includes major gastrointestinal and hepatobiliary resections. 
All Norwegian hospitals performing cancer resections are 
obliged to report data to NoRGast which records variables 
that might affect surgical outcome, such as pre-operative 
weight loss, BMI, ECOG-status, known severe pulmonary 
and cardiac disease as well as operative technique, and short-
term postoperative outcome measures including complica-
tions, reoperations, length of hospital stay, readmissions, and 
mortality rates. A detailed presentation of the registry has 
been published previously [24].
Patients were identified in the NoRGast database based 
on procedure codes according to the NCSP (NOMESCO 
Classification Of Surgical Procedures) [26] for rectal 
resection with formation of anastomosis (JGB00 through 
JGB07), rectal resection with end colostomy (codes JGB10 
and JGB11), and abdominoperineal resections (codes 
JGB30 through JGB36). The procedure codes were com-
bined with diagnosis code C20 for cancer < 15 cm from the 
anal verge assessed with rigid proctoscope according to the 
International Classification of Diseases version 10 (ICD-10) 
[27]. Some cases were registered with cancers located from 
15 cm or lower measured on rigid proctoscope, but errone-
ously had received the ICD-10 code C19 for rectosigmoid 
cancer at discharge, and these were also included. Patients 
with tumors other than adenocarcinoma were excluded. 
Emergency procedures and all procedures commenced by 
open access, as well as transanal total mesorectal excisions 
(taTME) were also excluded.
Data were linked to the Norwegian Colorectal Cancer 
Registry [25] for information on preoperative work-up, 
oncologic treatment upfront surgery, histopathology of the 
surgical specimen, and 90 days mortality rate based on the 
patients’ individual social security numbers.
Data quality
The coverage rate in NoRGast has increased during the study 
period from approximately 20% in 2014 to 75% in 2018 [28]. 
Variable completeness is 98–100%, much due to its web-
based registration system. The Norwegian Colorectal Cancer 
Registry includes annually more than 90% of all patients sur-
gically treated for rectal cancer [29]. However, this registry 
includes data from various sources, such as clinical reports 
on diagnosis and treatment, and histopathological reports. 
This results in some variations in variable completeness 
with missing data in up to 30% for some clinical variables, 
while variables from the histopathological reports have up 
to 90% completeness. However, as both registries overlap on 
a number of core variables, data linking results in an overall 
high degree of variable completeness. Patients with missing 
data in any variables included for analysis in this study were 
excluded, and number of missing values are documented in 
the attached tables. The manuscript was drafted in accord-
ance to the STROBE guidelines for observational studies 
[30].
Statistical analysis
Data were analyzed with SPSS version 26, (IBM, Armonk, 
New York, USA). For univariable analyses Pearson's Chi-
square test was used for categorical data, and two-sided T 
test or Mann–Whitney U test for continuous data. Confi-
dence interval (CI), standard deviation or inter quartile range 
(IQR) were calculated as appropriate. Univariable binary 
logistic regression was used to calculate unadjusted odds 
ratios (OR) for conversion rates, major complications, reop-
erations, 30 days mortality, and anastomotic leaks. A step-
wise backward multivariable logistic regression model was 
used to further analyze the relations between different pre-
dictors and outcomes, and adjusted odds ratios were reported 
for the final fitted models. Variables with a p value < 0.2 
in univariable analyses were included in the multivariable 
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analyses. All significant variables were tested for two-way 
interaction, and significant interactions were included in 
further multivariable analyses. The significance level was 
set to p < 0.05.
A linear regression model was made with the continuous 
variable as dependent variable, RR or LR as fixed factors 
and hospitals performing RR as covariate.
To address potential treatment assignment bias, a propen-
sity score matching was performed by including all avail-
able baseline variables. The matched sets were included in 
a new set of regression analyses. Match tolerance was set to 
0.01, and sampling was done without replacement. Robotic 
assistance was used as group indicator, and baseline char-
acteristics (age, gender, BMI, severe cardiac and pulmonary 
disease, diabetes, ASA-score, ECOG-score, and diabetes) 
were used as predictors.
Age was categorized into three groups (low < 65, mid 
65–80, and high > 80). ASA-scores were grouped into low 
ASA-scores (scores 1–2) and high ASA-scores (scores 3–4). 
ECOG-scores were dichotomized into low ECOG-score 
(0–1) and high ECOG-score (2–4). Severe pulmonary dis-
ease was defined as having FEV1 < 50% or a vital capac-
ity < 60% of predicted values. Severe cardiac disease was 
defined as NYHA classification 3–4, or severe arrythmia 
requiring mechanical support. Complications were recorded 
according to the Accordion grading system [31]. Major com-
plications were defined as Accordion grade of 3 or higher. 
Briefly, Accordion grade 3 is defined as any percutaneous, 
angiographic or endoscopic intervention, Accordion 4 is 
defined as intervention in general anesthesia or single-organ 
failure, Accordion 5 is defined as intervention in general 
anesthesia plus single- or multi-organ failure. Accordion 6 
is death within 30 days postoperatively. Anastomotic leak 
was defined as a leak requiring reoperation (grade C leaks) 
[32]. Only resections with formation of an anastomosis were 
included in analysis of anastomotic leak. Weight was classi-
fied by body mass index (BMI), and patients were grouped 
into 4 BMI-classes [33]; [< 18.5] [18.5–25] [25–30] [> 30]. 
Positive circumferential resection margin (positive CRM) 
was defined as CRM ≤ 1 mm, and positive distal resection 
margin (positive DRM) as DRM ≤ 1 mm.
Results
Patients
A total of 2302 patients were recorded in NoRGast with 
an NCSP procedural code for rectal resection in the study 
period. After excluding patients with other tumors than ade-
nocarcinoma, those undergoing taTME, endoscopic or emer-
gency procedures a total of 1796 patients were identified. 
Some 1284 had a laparoscopic procedure, of whom 909 had 
a conventional laparoscopic resection and 375 had a robotic 
assisted resection (Fig. 1). Sixteen hospitals contributed 
data, of which 7 performed both RR and LR. Demographi-
cal and clinical characteristics are presented in Table 1.
Conversion rates
The overall conversion rate was 95 out of 1284 patients 
(7.4%). In the RR group conversion rate was significantly 
lower as compared to the LR group, with 8 out of 375 (2.1%) 
and 87 out of 909 (9.6%), respectively (p < 0.001). Conver-
sion rate for LR performed in hospitals using both operative 
techniques was 51 out of 464 (11.0%) compared to 36 out of 
445 (8.1%) in hospitals using laparoscopic technique only 
(p = 0.137). In multivariable analyses, RR was associated 
with reduced risk for conversion with an aOR of 0.21 (95% 
CI 0.09–0.43) compared to LR. In addition, male gender 
(aOR 1.86, 95% CI. 1.14–3.06), BMI > 30 (aOR 2.64, 95% 
CI 1.51–4.61), and severe cardiac disease (aOR 2.16, 95% 
CI 1.08–4.31) were independent predictors for conversion 
(Table 2). The Hartmann procedure was associated with a 
higher conversion rate (aOR 2.88, 95% CI 1.35–6.13) than 
Paents registered and matched from both NoRGast  
and the Colorectal Cancer Registry (n= 2302) 
Excluded for locaon other than 
rectal, and histology other than 
adenocarcinomas (n=402) 
Excluded taTME (n= 86), 
endoscopic (n= 2) and 
emergency 
 procedure (n= 16) 
Excluded open access as 
intenon-to-treat (n=512) 
Scheduled laparoscopic resecons for rectal 
adenocarcinomas  
(n=1284) 
Roboc ass. resecons 
(n= 375) 
Std. laparoscopic resecons 
(n= 909) 
Fig. 1  Flowchart
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low anterior resections (LAR), with abdominoperineal 
resections (APR) as reference (Table 2).
A separate analysis on the risk factors gender and BMI 
revealed an especially high conversion rate for male patients 
with BMI > 30 in the LR group (Table 3). The OR for con-
version in male patients with BMI > 30 was 0.23 (95% CI 
0.07–0.83) for RR with LR as reference. A total of 730 
patients were included after propensity score matching, 
with 65 exact matches and 289 fuzzy matches. After pro-
pensity score matching, RR compared to LR (aOR 0.19, 95% 
CI 0.09–0.42) as well as male gender (aOR 2.44, 95% CI 
1.14–5.19) remained significant predictors for conversion.
Postoperative complications
Major complications, 30-day mortality rates and reoperation 
rates did not differ between the LR and RR group (Table 4). 
The overall anastomotic leak rate was 41 out of 743 (5.5%) 
and did not differ between LR and RR. Rates of major com-
plications and reoperations were higher following converted 
procedures compared to procedures completed laparoscopi-
cally, with complication rates of 20 out of 95 (21.1%) vs 135 
out of 1189 (11.4%) (p = 0.005) and reoperation rates of 13 
out of 95 (13.7%) vs 93 out of 1189 (7.8%) (p = 0.046).
Conversion, male gender, severe pulmonary or cardiac 
disease, and BMI > 30 were independent predictors for major 
complications in multivariable regression analysis (Table 5). 
After propensity score matching only male gender, severe 
cardiac disease, and BMI > 30 remained significant. In 
multivariable regression analysis of 30-day mortality only 
ECOG-score > 2 was found to be an independent predictor 
(aOR 21.10, 95% CI 3.27–136.26) p = 0.001). For reopera-
tion, male gender (aOR 2.25, 95% CI 1.41–3.59, p = 0.001), 
severe pulmonary disease (aOR 2.74, 95% CI 1.26–5.93, 
p = 0.011), and LAR as operative technique with APR as ref-
erence (aOR 2.72, 95% CI 1.64–4.53, p < 0.001) were inde-
pendent predictors in multivariable regression analyses. For 
anastomotic leak, only male gender was a predictor (aOR 
2.44, 95% CI 1.15–5.19, p = 0.020). All predictors from 
initial multivariable logistic regression analysis remained 
significant in propensity score matched analysis for 30-day 
mortality rates, reoperations, and anastomotic leak.
Length of in-hospital stay (LOS) was shorter in the RR 
group compared to LR; median 5 vs 6 days (p = 0.001). 
Patients who underwent conversion to open access had a 
median LOS of 8 days compared to 6 days after procedures 
completed laparoscopically (p = 0.001) (Table 4). There 
were, however, no differences in LOS between LR and RR 
in hospitals operating with both techniques.
Histopathological results
The overall rates of positive CRM and DRM were 51 out of 
1090 (4.7%) and 7 out of 1075 (0.7%) and were similar in 
the RR and LR group (Table 4). The rate of positive CRM 
was higher (9 out of 88, 10.2%) following converted proce-
dures compared to procedures completed laparoscopically 
(42 out of 1002, 4.2%, p = 0.010). A higher proportion of 
positive CRM was seen following APR compared with other 
operative techniques (APR 33 out of 357, 9.2%, LAR 12 out 
of 636, 1.9% and Hartmann 6 out of 97, 6.2%, p < 0.001). 
Further, surgery for low tumors (0–5 cm above anal verge) 
resulted in higher rates of positive CRM compared with 
Table 1  Baseline characteristics
Values in parentheses are percentages unless indicated otherwise
LR laparoscopic resections, RR robotic resections
*Chi-square analyses
a Cm from anal verge measured with rigid proctoscope
b Low anterior resection
c Abdominoperineal resection
Total n = 1284 LR n = 909 RR n = 375 p value*
Sex
 Male 782 551 (61) 231 (62) 0.743
 Female 502 358 (39) 144 (38)
Age, median 
(IQR)
69 (60–76) 69 (60–76) 69 (60–75) 0.760
BMI
  < 18.5 24 18 (2) 6 (1.7) 0.067
 18.8–25 511 380 (42.4) 131 (36.1)
 25–30 496 350 (39.1) 146 (40.2)
  > 30 228 148 (16.5) 80 (22.0)
ASA-score
 Low (1–2) 871 640 (70.4) 231 (61.6) 0.002
 High (3–4) 413 269 (29.6) 144 (38.4)
ECOG-class
 Low (0–1) 1210 854 (94.1) 356 (96.5) 0.078
 High (2–4) 67 54 (5.9) 13 (3.6)
Diabetes 134 92 (10.1) 42 (11.2) 0.565
Pulmonary 
disease
48 44 (4.8) 4 (1.1) 0.001
Cardiac disease 73 65 (7.2) 8 (2.1)  < 0.001
Radio(chemo)
therapy
375 323 (25.5) 143 (38.1)  < 0.001
Tumor  levela
 Low (0–5 cm) 244 159 (26.6) 85 (35.0) 0.045
 Mid 
(5–10 cm)
332 224 (37.5) 108 (40.6)
 High 
(10–15 cm)
287 214 (35.8) 73 (27.3)
Operative tech-
nique
  LARb 743 552 (60.7) 191 (50.9) 0.003
  APRc 432 280 (30.8) 152 (40.5)
 Hartmann 109 77 (8.5) 32 (8.5)
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intermediate (5–10 cm) and high (10–15 cm) tumors, with 
23 out of 206 (11.2%), 9 out of 297 (3.0%), and 5 out of 250 
(2.0%), respectively (p < 0.001). Tumor diameter and tumor 
stage were not associated with higher rates of positive CRM.
A mean number of 14 lymph nodes were retrieved from 
the specimen in the RR group compared 18 in the LR group 
(p = 0.001). In hospitals performing both LR and RR there 
were no differences in lymph node retrieval between the 
two groups, except for one hospital where LR resulted in 
fewer lymph nodes as compared to RR (Table 6). ANCOVA 
analysis comparing mean number of lymph nodes between 
the RR group and the LR group correcting for hospital 
showed no differences between the two methods (p = 0.550).
Discussion
This study on a national cohort of patients who underwent 
laparoscopic resections for rectal cancer demonstrates that 
conversion rate was lower with robotic assistance compared 
Table 2  Regression analyses of 








All patients 95/1284 (7.4)
Age group
  < 65 37/503 (7.4) Ref 0.411
 65–80 43/631 (6.8) 0.91 (0.58–4.45)
  > 80 15/150 (10.0) 1.40 (0.75–2.63)
Sex
 Female 24/502 (4.8) Ref 0.014 Ref 0.014
 Male 71/782 (9.1) 1.98 (1.23–3.21) 1.86 (1.14–3.06)
WHO ECOG-score
 0, 1 89/1210 (7.4) Ref 0.974
 2, 3, 4 5/67 (7.5) 1.02 (0.39–2.59)
ASA classification
 1–2 63/871 (7.2) Ref 0.742
 3–4 32/413 (7.7) 1.08 (0.69–1.68)
Severe pulmonary disease
 No 93/1236 (7.5) Ref 0.391
 Yes 2/48 (4.2) 0.53 (0.29–2.34)
Severe cardiac disease
 No 83/1211 (6.9) Ref 0.003 Ref 0.029
 Yes 12/73 (16.4) 2.67 (1.39–5.16) 2.16 (1.08–4.31)
Med. Diabetes
 No 79/1150 (6.9) Ref 0.036
 Yes 16/134 (11.9) 1.84 (1.04–3.25)
Weight class (BMI)
  < 18.5 1/24 (4.2) 0.72 (0.09–5.54) 0.007 0.87 (0.12–6.89) 0.002
 18.5–25 29/511 (5.7) Ref Ref
 25–30 32/496 (6.5) 1.15 (0.68–1.93) 1.08 (0.63–1.83)
  > 30 29/228 (12.7) 2.42 (1.41–4.16) 2.64 (1.51–4.61)
Radio(chemo)therapy
 No 71/909 (7.8) Ref 0.381
 Yes 24/375 (6.4) 0.81 (0.50–1.30)
Operative technique
 LAR 60/743 (8.0) 1.72 (1.03–2.87) 0.012 1.66 (0.97–2.84) 0.021
 Hartmann 14/109 (14.3) 2.88 (1.42–5.88) 2.88 (1.35–6.13)
 APR 21/432 (4.8) Ref Ref
Robotic assistance
 No 87/909 (9.6) Ref  < 0.001 Ref  < 0.001
 Yes 8/375 (2.1) 0.21 (0.09–0.43) 0.22 (0.10–0.46)
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Table 3  Rate of conversion 
stratified by sex and BMI
Values in parentheses are percentages unless indicated otherwise
RR robotic resection, LR laparoscopic resection
a OR for conversion in RR with LR as reference
*Chi-square analysis
Conversion rate
RR LR ORa (95% CI)
Male (all cases) 6 out of 231 (2.6) 65 out of 551 (11.8) p < 0.001*
 Male, BMI > 30 3 out of 52 (5.77) 19 out of 91 (20.88) 0.23 (0.07–0.83) p = 0.024
 Male, BMI < 30 3 out of 172 (1.74) 42 out of 451 (9.31) 0.17 (0.06–0.57) p = 0.004
Female (all cases) 2 out of 114 (1.4) 22 out of 358 (6.1) p = 0.024*
 Female, BMI > 30 0 out of 28 (0.00) 7 out of 57 (12.28) 0.12 (0.01–2.15) p = 0.149
 Female, BMI < 30 2 out of 111 (1.80) 15 out of 297 (5.05) 0.36 (0.08–1.53) p = 0.162
Table 4  Postoperative complications and histopathological results
Values in parentheses are percentages unless indicated otherwise




a LOS, In-hospital length of stay
b Circumferential resection margin. Missing values in this variable n = 194
c Distal resection margin, measured in centimeters. Missing values in this variable n = 209
d Proximal resection margin, measured in centimeters. Missing values in this variable n = 280
e Lymph nodes yielded
f Missing values in this variable n = 627
LR RR p values* CC** CL*** p values*
30-day mortality 3 (0.3) 2 (0.2) 0.592 1 (1.1) 4 (0.3) 0.280
90-day mortality 11 (1.2) 5 (1.3) 0.856 3 (3.2) 13 (1.1) 0.081
Major complications 112 (12.3) 43 (11.5) 0.669 20 (21.2) 135 (11.4) 0.005
Conversion rate 87 (9.6) 8 (2.1)  < 0.001
Anastomotic leak 27 (4.9) 14 (7.7) 0.203 5 (8.3) 36 (5.3) 0.319
Reoperation 71 (7.8) 35 (9.3) 0.367 13 (12.3) 93 (7.8) 0.046
Tumor perforation 5 (0.6) 2 (0.6) 0.988 3 (3.8) 4 (0.4)  < 0.001
LOSa median (IQR) 6 (4–9) 5 (3–7) 0.001 8 (6–12) 6 (4–8) 0.001
Single-organ failure 22 (2.4) 5 (1.3) 0.217 3 (3.2) 24 (2.0) 0.456
Multi-organ failure 3 (0.3) 2 (0.5) 0.595 2 (2.1) 3 (0.3) 0.005
Histopathological results
LR RR p values CC CL p values
Positive  CRMb 35 (4.6) 16 (4.8) 0.885 9 (10.2) 42 (4.2) 0.010
Positive  DRMc 6 (0.8) 1 (0.3) 0.376 1 (1.1) 6 (0.6) 0.547
Median  DRMc (IQR) 3.0 (1.8–4.0) 3.5 (2.0–4.5) 0.002 2.6 (2.0–4.0) 3.0 (2.0–4.4) 0.367
Median  PRMd (IQR) 15.0 (11.0–20.0) 13.5 (10.0–17.0) 0.001 18.0 (12.0–23.0) 14.0 (10.3–19.0) 0.001
L.nodee median (IQR) 16 (12–21) 13 (11–17) 0.001 16 (13–22) 15 (12–20) 0.505
Stagef
 1 196 (41.4) 66 (36.1) 0.486 14 (28.6) 248 (40.8) 0.135
 2 121 (25.5) 38 (20.8) 11 (22.5) 148 (24.3)
 3 108 (22.8) 54 (29.5) 14 (28.6) 148 (24.3)
 4 49 (10.3) 25 (13.7) 10 (20.4) 64 (10.5)
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to standard laparoscopy. Further, conversion to open access 
surgery was associated with higher rates of major complica-
tions, longer hospital stay, and unfavorable histopathological 
results.
These results are corroborated by data from a recent 
meta-analysis of RCTs and propensity score matched stud-
ies [17] as well as a large single center study on 600 patients 
[16], both showing lower conversion rates with robotic 
assistance compared to conventional laparoscopy in rectal 
cancer patients, [16, 17]. In contrast, the large international 
multi-center ROLARR trial found no difference in conver-
sion rates between RR and LR [18]. However, according 
to a post hoc multi-level logistic regression analysis tak-
ing into account the participating surgeon’s experience with 
robotic surgery, the lack of difference in conversion rates 
between the two techniques in this multi-center trial could 
be explained by a learning effect [34].
A conversion rate of 2.1% with RR and 9.6% with LR is 
generally low compared to other large studies on both lapa-
roscopic and robotic rectal resections, where reported rates 
Table 5  Regression analyses 
of risk factors for major 
complications
Rate (%) Univariable Multivariable
OR (95% CI) p value aOR (95% CI) p value
All patients 155/1284 (12.1)
Age group
  < 65 68/503 (13.5) Ref 0.192
 65–80 75/631 (11.9) 0.86 (0.61–1.23)
  > 80 12/150 (8.0) 0.56 (0.29–1.06)
Sex
 Female 43/502 (8.6) Ref 0.002 Ref 0.009
 Male 112/782 (14.3) 1.78 (1.23–2.59) 1.67 (1.14–2.44)
WHO ECOG-score
 0, 1 148/1210 (12.2) Ref 0.664
 2, 3, 4 7/67 (10.4) 0.84 (0.38–1.87)
Severe pulmonary disease
 No 139/1236 (11.2) Ref  < 0.001 Ref  < 0.001
 Yes 16/48 (33.3) 3.95 (2.11–7.48) 3.34 (1.72–6.46)
Severe cardiac disease
 No 131/1211 (10.8) Ref  < 0.001 Ref  < 0.001
 Yes 24/73 (32.9) 4.04 (2.39–6.79) 3.42 (1.97 (5.94)
Weight class (BMI)
  < 18.5 2/24 (8.3) 0.98 (0.23–4.35) 0.007
 18.5–25 43/511 (8.4) Ref
 25–30 70/496 (14.1) 1.79 (1.19–2.67)
  > 30 37/228 (16.2) 2.11 (1.32–3.38)
Med. Diabetes
 No 135/1150 (10.5) Ref 0.285
 Yes 20/134 (14.9) 1.32 (0.79–2.19)
ASA classification
 1–2 102/871 (11.7) Ref 0.564
 3–4 53/413 (12.8) 1.11 (0.79–1.58)
Operative technique
 LAR 105/743 (14.1) Ref 0.020 Ref 0.010
 Hartmann 7/109 (6.4) 0.42 (0.19–0.92 0.36 (0.16–0.81)
 APR 43/432 (10.0) 0.67 (0.46–0.78) 0.66 (0.45–0.97)
Robotic assistance
 No 112/909 (12.3) 0.669
 Yes 43/375 (11.5) 0.92 (0.63–1.34)
Conversion
 Yes 20/95 (21.1) 2.09 (1.23–5.52) 0.006 1.85 (1.07–3.23) 0.029
 No 135/1189 (11.4) Ref Ref
 Surgical Endoscopy
1 3
vary between 5.0 and 8.1% for RR and 12.2 and 15.4% for 
LR [16–18]. This could indicate that the operating surgeons 
had a high level of experience with both robotic assisted and 
laparoscopic techniques.
Male gender, BMI > 30, and severe cardiac disease were 
identified as risk factors associated with conversion to open 
surgery, which is in line with other studies [16, 35, 36]. In a 
study by Crippa et al., robotic surgery was associated with 
lower conversion rate in obese patients [14]. In the present 
study, the conversion rate was especially high for males 
with BMI > 30 who underwent LR, and the risk for con-
version in this group was significantly lower with robotic 
assistance (Table 3). This indicates that robotic assistance 
aids in completing surgery laparoscopically especially in 
the more challenging obese patients combined with a nar-
row male pelvis. The finding of severe cardiac disease as 
an independent risk factor for conversion has to our knowl-
edge not been addressed in the literature. The data avail-
able for this study do not provide further information to 
elaborate this finding.
Rates of major complications, 30 day mortality, reopera-
tions, and anastomotic leak did not differ between RR and 
LR, which is in line with other large studies [7, 16, 18, 37]. 
While some studies have used standardized complication 
scores like Accordion grading score [38] or Clavien-Dindo 
score [5], other studies recorded complications according 
to custom definitions which vary greatly and make direct 
comparison difficult. A review of 8 studies including 592 
patients undergoing laparoscopic or robotic assisted LAR 
showed that the overall complication rate was significantly 
lower in the RR group compared to LR [39]; however, the 
definition of complications differed between the included 
studies. In comparison, there were no differences in com-
plication rates between RR and LR in the ROLARR trial 
comprising 461 patients [18]. The overall rate of major com-
plications in the present study was low, as almost 9 out of 10 
patients went through elective rectal cancer surgery without 
any major complication.
Conversion to open access was followed by higher rates of 
major complications, reoperations, longer LOS, higher rates 
of positive CRM, and tumor-near bowel-perforation. Higher 
rates of complications have been associated with conversion 
of laparoscopic colon cancer resections in several studies 
[3–7]. In a study with prospectively collected data of 470 
patients who underwent laparoscopic colorectal resections 
including 192 rectal resections, postoperative complication 
rates were significantly higher for patients who experienced 
conversion to open access, with a rate of 56.1% versus 16.8% 
when resections were completed laparoscopically [37]. This 
finding is supported by the present study, although the dif-
ference in complication rates was less profound.
Histopathological assessment included CRM/DRM and 
number of retrieved lymph nodes in the specimen. Total 
number of lymph nodes is one of the key quality measures 
for assessing the histopathological result following colo-
rectal surgery [40]. The present study showed significantly 
lower numbers of harvested lymph nodes in the RR group 
compared with the LR group. However, subgroup analysis 
indicated that this was related to local hospital or labora-
tory differences rather than between RR and LR, as there 
was no difference in number of retrieved lymph nodes after 
LR and RR in hospitals operating with both methods. Large 
differences between pathology laboratories in lymph node 
retrieval have previously been shown in other studies [41, 
42]. In the present study, the proportion of patients with 
neoadjuvant treatment was significantly higher in the RR 
group. This was probably related to a larger share of low 
tumors in the RR group which more often meet the criteria 
for neoadjuvant treatment. Neoadjuvant treatment is well 
known to be associated with a lower number of specimen 
lymph nodes. In the ROLARR trial, mean number of lymph 
nodes retrieved by robotic resections were 24.1, compared to 
23.2 for laparoscopic resections [18]. In the COLORII trial 
the median number of lymph nodes retrieved was 13 for the 
laparoscopic resections [7], which compares well with the 
present study.
Table 6  Lymph nodes retrieved 
with LR and RR in hospitals 
performing both techniques
Significant values (p < 0.05) are marked in bold
RR robotic resection, LR laparoscopic resection
Center number n total n RR
RR LR p value
Mean n. lymphnodes 
(Std.dev)
Mean n. lymphnodes 
(Std.dev)
1 158 6 26.5 (12.5) 21.1 (11.1) 0.339
2 118 60 13.7 (5.8) 15.1 (4.8) 0.148
3 75 58 15.2 (5.8) 16.1 (5.9) 0.564
4 123 4 20.8 (3.3) 15.7 (7.7) 0.044
5 32 19 20.7 (7.8) 26.6 (13.5) 0.174
6 64 34 15.9 (5.9) 16.9 (4.8) 0.482
7 269 194 12.6 (4.9) 13.0 (5.2) 0.562
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The overall positive CRM was 4.7% in the present 
study, which is lower than both the COLORII trial [7] 
(7.05% for LR) and the ROLARR trial [18] (6.3% for LR 
and 5.1% for RR). In the present study, positive CRM was 
more frequent in converted cases, low tumors and tumors 
resected by APR. Despite a higher proportion of APR and 
lower tumors in the RR group, no difference was seen 
regarding positive CRM. This could indicate that robotic 
assistance reduces the risk for involved CRM in patients 
operated with APR. In this study however, the reason for 
conversion was not recorded. In a review [43] of 18 studies 
on colorectal cancer patients, 3 studies on rectal cancer 
patients stated that the most common reasons for conver-
sion were advanced tumors, obesity, narrow pelvis, and 
adhesions. The higher rates of positive CRM in specimens 
from converted procedures could reflect difficult laparo-
scopic dissection where conversion to open access enabled 
to finalize the procedure but could not undo the damage 
caused by suboptimal dissection.
There are some limitations to this study. The complete-
ness of the mesorectal fascia is an important histopathologi-
cal quality measure [44, 45], but this variable was not availa-
ble from the Norwegian Colorectal Cancer Registry. Another 
limitation is that NoRGast is a newly established registry 
with low coverage rates during the first years of inclusion. 
Furthermore, it is possible that surgeons performing robotic 
rectal resections are those who previously had developed 
high surgical skills in conventional laparoscopy. However, 
rectal cancer surgery in Norway has been centralized before 
the introduction of conventional laparoscopic rectal resec-
tion, and the same surgeons are performing LR and RR at 
centers offering both techniques. The higher conversion rate 
in LR also in these centers makes this bias unlikely.
Moreover, the present study is an observational study, 
and the low conversion rate associated with robotic resection 
could be a result of confounders which were not recorded 
as variables in the registries. However, separate analyses on 
hospital level to detect whether conversion rate was depend-
ent on robot system accessibility, showed significantly 
higher conversion rates with LR also in hospitals with access 
to such operating systems. Furthermore, propensity score 
matching was also performed to eliminate bias otherwise 
only accounted for by an RCT.
This study is based on compound data from two national 
quality registries covering the surgical and oncological qual-
ity of surgical treatment of rectal cancer and shows real time 
results from treatment outside the strict frames of an RCT. 
Mandatory inclusion of patients from all hospitals perform-
ing rectal cancer surgery enables the possibility to obtain 
a large dataset of unselected patient population suited for 
research using advanced statistical methods to minimize bias 
and confounding. This approach offers results that reflect 
national daily practice. The degree of external validity would 
depend on a similar homogenous population and healthcare 
provision.
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